Clinical Trial

A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

Name: A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction — clinical trial record (NCT06782594)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated January 20, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.

Summary

This study is a multicenter, randomized, double-blind, parallel, placebo-controlled phase II clinical study.

Trial Details

NCT Number	NCT06782594
Lead Sponsor	Shandong New Time Pharmaceutical Co., LTD
Conditions	Postoperative Gastrointestinal Dysfunction
Enrollment	150 participants
Start Date	2024-10-18
Primary Completion	2025-06 (estimated)
Study Completion	2025-10 (estimated)
Updated on ClinicalTrials.gov	2025-01-20